Your browser doesn't support javascript.
loading
Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis.
Geersing, Geert-Jan; Takada, Toshihiko; Klok, Frederikus A; Büller, Harry R; Courtney, D Mark; Freund, Yonathan; Galipienzo, Javier; Le Gal, Gregoire; Ghanima, Waleed; Kline, Jeffrey A; Huisman, Menno V; Moons, Karel G M; Perrier, Arnaud; Parpia, Sameer; Robert-Ebadi, Helia; Righini, Marc; Roy, Pierre-Marie; van Smeden, Maarten; Stals, Milou A M; Wells, Philip S; de Wit, Kerstin; Kraaijpoel, Noémie; van Es, Nick.
Afiliação
  • Geersing GJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Takada T; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Klok FA; Department of General Medicine, Shirakawa Satellite for Teaching And Research (STAR), Fukushima Medical University, Fukushima, Japan.
  • Büller HR; Department of Medicine, Thrombosis and Haemostasis, Dutch Thrombosis Network, Leiden University Medical Center, Leiden, the Netherlands.
  • Courtney DM; Department of Medicine, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Freund Y; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
  • Galipienzo J; Sorbonne University, Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Le Gal G; Service of Anesthesiology, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Ghanima W; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Kline JA; Department of Medicine, Østfold Hospital Trust, Norway and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Huisman MV; Department of Emergency Medicine, Wayne State School of Medicine, Detroit, Michigan, United States of America.
  • Moons KGM; Department of Medicine, Thrombosis and Haemostasis, Dutch Thrombosis Network, Leiden University Medical Center, Leiden, the Netherlands.
  • Perrier A; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Parpia S; Cochrane Netherlands, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Robert-Ebadi H; Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Righini M; Department of Oncology, McMaster University, Hamilton, Canada.
  • Roy PM; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
  • van Smeden M; Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Stals MAM; Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Wells PS; UNIV Angers, UMR (CNRS 6015-INSERM 1083) and CHU Angers, Department of Emergency Medicine, F-CRIN InnoVTE, Angers, France.
  • de Wit K; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Kraaijpoel N; Department of Medicine, Thrombosis and Haemostasis, Dutch Thrombosis Network, Leiden University Medical Center, Leiden, the Netherlands.
  • van Es N; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.
PLoS Med ; 19(1): e1003905, 2022 01.
Article em En | MEDLINE | ID: mdl-35077453
ABSTRACT

BACKGROUND:

The challenging clinical dilemma of detecting pulmonary embolism (PE) in suspected patients is encountered in a variety of healthcare settings. We hypothesized that the optimal diagnostic approach to detect these patients in terms of safety and efficiency depends on underlying PE prevalence, case mix, and physician experience, overall reflected by the type of setting where patients are initially assessed. The objective of this study was to assess the capability of ruling out PE by available diagnostic strategies across all possible settings. METHODS AND

FINDINGS:

We performed a literature search (MEDLINE) followed by an individual patient data (IPD) meta-analysis (MA; 23 studies), including patients from self-referral emergency care (n = 12,612), primary healthcare clinics (n = 3,174), referred secondary care (n = 17,052), and hospitalized or nursing home patients (n = 2,410). Multilevel logistic regression was performed to evaluate diagnostic performance of the Wells and revised Geneva rules, both using fixed and adapted D-dimer thresholds to age or pretest probability (PTP), for the YEARS algorithm and for the Pulmonary Embolism Rule-out Criteria (PERC). All strategies were tested separately in each healthcare setting. Following studies done in this field, the primary diagnostic metrices estimated from the models were the "failure rate" of each strategy-i.e., the proportion of missed PE among patients categorized as "PE excluded" and "efficiency"-defined as the proportion of patients categorized as "PE excluded" among all patients. In self-referral emergency care, the PERC algorithm excludes PE in 21% of suspected patients at a failure rate of 1.12% (95% confidence interval [CI] 0.74 to 1.70), whereas this increases to 6.01% (4.09 to 8.75) in referred patients to secondary care at an efficiency of 10%. In patients from primary healthcare and those referred to secondary care, strategies adjusting D-dimer to PTP are the most efficient (range 43% to 62%) at a failure rate ranging between 0.25% and 3.06%, with higher failure rates observed in patients referred to secondary care. For this latter setting, strategies adjusting D-dimer to age are associated with a lower failure rate ranging between 0.65% and 0.81%, yet are also less efficient (range 33% and 35%). For all strategies, failure rates are highest in hospitalized or nursing home patients, ranging between 1.68% and 5.13%, at an efficiency ranging between 15% and 30%. The main limitation of the primary analyses was that the diagnostic performance of each strategy was compared in different sets of studies since the availability of items used in each diagnostic strategy differed across included studies; however, sensitivity analyses suggested that the findings were robust.

CONCLUSIONS:

The capability of safely and efficiently ruling out PE of available diagnostic strategies differs for different healthcare settings. The findings of this IPD MA help in determining the optimum diagnostic strategies for ruling out PE per healthcare setting, balancing the trade-off between failure rate and efficiency of each strategy.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Embolia Pulmonar / Interpretação Estatística de Dados / Atenção à Saúde Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Embolia Pulmonar / Interpretação Estatística de Dados / Atenção à Saúde Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda